皮下注射恩沃利单抗治疗中国晚期实体瘤的 Ⅰ期临床研究.
- Published in:
- Chinese Journal of Oncology, 2023, v. 45, n. 10, p. 898, doi. 10.3760/cma.j.cn112152-20220530-00373
- By:
- Publication type:
- Article
Works matching IS 02533766 AND DT 2023 AND VI 45 AND IP 10
Results: 8
1
2
安罗替尼治疗晚期肉瘤的有效性和安全性 分析.
- Published in:
- Chinese Journal of Oncology, 2023, v. 45, n. 10, p. 904, doi. 10.3760/cma.j.cn112152-20210820-00632
- By:
- Publication type:
- Article
3
安罗替尼联合放疗三线治疗广泛期小细胞肺癌的Ⅱ期临床研究.
- Published in:
- Chinese Journal of Oncology, 2023, v. 45, n. 10, p. 892, doi. 10.3760/cma.j.cn112152-20220324-00204
- By:
- Publication type:
- Article
4
Hsa_circ_0000392靶向miR－145－5p/CRKL轴调控细胞外调节蛋白激酶通路影响宫颈癌的辐射敏感性.
- Published in:
- Chinese Journal of Oncology, 2023, v. 45, n. 10, p. 879, doi. 10.3760/cma.j.cn112152-20201217-01075
- By:
- Publication type:
- Article
5
食管癌根治术腹部淋巴结清扫中国专家共识 (2023 版).
- Published in:
- Chinese Journal of Oncology, 2023, v. 45, n. 10, p. 871, doi. 10.3760/cma.j.cn112152-20230330-00136
- By:
- Publication type:
- Article
6
激素受体阳性人表皮生长因子受体 2 阴性 早期乳腺癌术后辅助治疗多基因检测应用 专家共识 (2023 版).
- Published in:
- Chinese Journal of Oncology, 2023, v. 45, n. 10, p. 863, doi. 10.3760/cma.j.cn112152-20230627-00266
- By:
- Publication type:
- Article
7
乳腺癌内分泌治疗药物药学服务指南 (2023 版).
- Published in:
- Chinese Journal of Oncology, 2023, v. 45, n. 10, p. 834, doi. 10.3760/cma.j.cn112152-20230823-00097
- By:
- Publication type:
- Article
8
乳腺癌诊疗指南(2022年版).
- Published in:
- Chinese Journal of Oncology, 2023, v. 45, n. 10, p. 803, doi. 10.3760/cma.j.cn112152-20230706-00281
- Publication type:
- Article